ReviewSmall methods2026
Structural, Compositional, and Dielectric State Profiling in Label-Free Single-Cell Monitoring.
Review in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Individual cells sense and transition between functional states, and the distribution of these states over time determines drug response, disease progression, and cell manufacturing outcomes. However, repeated measurement is difficult with label-based acquisition, as photobleaching, phototoxicity, and probe-induced perturbation accumulate. Label-free monitoring that leverages intrinsic physical signals circumvents these constraints, shifting the analytical burden from label chemistry to instrumental drift. In this review, we organize this field into three measurement modalities, including imaging-based, vibrational spectroscopy-based, and electrical sensing-based, each linked to distinct intrinsic state variables. Anchoring each modality to biological state variables such as structural organization, molecular composition, or dielectric architecture enables a physics-grounded framework that clarifies how intrinsic signals map onto functional cellular phenotypes in longitudinal monitoring. We describe the measurement principle, drift sources, and feature space for each modality, and evaluate representative platforms against a frame spanning design, feature definition, quantitative performance, and validation practice. Dominant analytical constraints differ systematically across modalities, motivating integrative architectures in which complementary modalities resolve ambiguities that no single modality can disentangle. We further discuss shared requirements for calibration, standardized reporting, and multimodal integration, and outline requirements in hardware miniaturization, edge inference, and artificial intelligence-guided molecular attribution to support scalable quantitative single-cell phenotyping.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.